JP Morgan Chase’s Apollo Endosurgery, Inc. APEN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-1,338,150
| Closed | -$13.3M | – | 7562 |
|
|
2023
Q1 | $13.3M | Buy |
1,338,150
+263,800
| +25% | +$2.61M | ﹤0.01% | 2021 |
|
|
2022
Q4 | $10.7M | Buy |
+1,074,350
| New | +$8.01M | ﹤0.01% | 2187 |
|
|
2022
Q2 | – | Sell |
-32,125
| Closed | -$194K | – | 7097 |
|
|
2022
Q1 | $194K | Buy |
32,125
+22,392
| +230% | +$136K | ﹤0.01% | 5209 |
|
|
2021
Q4 | $82K | Buy |
+9,733
| New | +$85K | ﹤0.01% | 5767 |
|
|
2020
Q4 | – | Sell |
-7
| Closed | – | – | 6052 |
|
|
2020
Q3 | $0 | Hold |
7
| – | – | ﹤0.01% | 5894 |
|
|
2020
Q2 | $0 | Buy |
+7
| New | +$14 | ﹤0.01% | 5811 |
|
|
2019
Q1 | – | Sell |
-600
| Closed | -$2K | – | 6126 |
|
|
2018
Q4 | $2K | Sell |
600
-57,827
| -99% | -$286K | ﹤0.01% | 5606 |
|
|
2018
Q3 | $419K | Buy |
58,427
+46,995
| +411% | +$365K | ﹤0.01% | 4361 |
|
|
2018
Q2 | $80K | Buy |
11,432
+8,157
| +249% | +$50.7K | ﹤0.01% | 4917 |
|
|
2018
Q1 | $20K | Buy |
+3,275
| New | +$20.6K | ﹤0.01% | 5080 |
|
|
2017
Q4 | – | Sell |
-25,936
| Closed | -$119K | – | 5630 |
|
|
2017
Q3 | $119K | Buy |
+25,936
| New | +$137K | ﹤0.01% | 4257 |
|
|
2016
Q3 | – | Sell |
-127
| Closed | -$2K | – | 4898 |
|
|
2016
Q2 | $2K | Buy |
+127
| New | +$1.91K | ﹤0.01% | 4623 |
|
JP Morgan Chase's APEN Position: Q2 2023 in Review
JP Morgan Chase sold out of Apollo Endosurgery, Inc. (APEN) in Q2 2023, closing a stake of 1,338,150 shares — an estimated $13.3M sold.
JP Morgan Chase first reported a position in APEN in Q2 2016 and held it in 12 quarters. The position peaked at $13.3M in Q1 2023. 0 funds tracked by Wall St. Rank hold APEN as of Q2 2023.
- JP Morgan Chase reported no remaining Apollo Endosurgery, Inc. position as of Q2 2023 after selling out during the quarter.
- JP Morgan Chase sold 1,338,150 Apollo Endosurgery, Inc. shares in Q2 2023, an estimated $13.3M.
- JP Morgan Chase first reported a position in Apollo Endosurgery, Inc. in Q2 2016 and held it in 12 quarters.
- JP Morgan Chase's Apollo Endosurgery, Inc. position peaked at $13.3M in Q1 2023.
- 0 funds tracked by Wall St. Rank held Apollo Endosurgery, Inc. as of Q2 2023.
Based on JP Morgan Chase's 13F filing for Q2 2023, filed 11 Aug 2023.